Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide.

Source:http://linkedlifedata.com/resource/pubmed/id/10929273

Download in:

View as

General Info

PMID
10929273